303 related articles for article (PubMed ID: 16157536)
21. Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
Sugae S; Suzuki A; Takahashi N; Minamimoto R; Cheng C; Theeraladanon C; Endo I; Togo S; Inoue T; Shimada H
Ann Nucl Med; 2008 Jan; 22(1):65-72. PubMed ID: 18250989
[TBL] [Abstract][Full Text] [Related]
22. Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
van Eerd JE; Oyen WJ; Harris TD; Rennen HJ; Edwards DS; Corstens FH; Boerman OC
J Nucl Med; 2005 May; 46(5):786-93. PubMed ID: 15872352
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; Edwards DS; Barrett JA; van der Meer JW; Corstens FH
J Nucl Med; 1997 Aug; 38(8):1310-5. PubMed ID: 9255174
[TBL] [Abstract][Full Text] [Related]
24. Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
van Eerd JE; Laverman P; Oyen WJ; Harris TD; Edwards DS; Ellars CE; Corstens FH; Boerman OC
J Nucl Med; 2004 Jan; 45(1):89-93. PubMed ID: 14734679
[TBL] [Abstract][Full Text] [Related]
25. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
[TBL] [Abstract][Full Text] [Related]
26. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
28. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
Zhao S; Kuge Y; Tsukamoto E; Mochizuki T; Kato T; Hikosaka K; Hosokawa M; Kohanawa M; Tamaki N
Eur J Nucl Med; 2001 Jun; 28(6):730-5. PubMed ID: 11440033
[TBL] [Abstract][Full Text] [Related]
29. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
30. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit.
Babich JW; Graham W; Barrow SA; Dragotakes SC; Tompkins RG; Rubin RH; Fischman AJ
J Nucl Med; 1993 Dec; 34(12):2176-81. PubMed ID: 8254406
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model.
van Kouwen MC; Laverman P; van Krieken JH; Oyen WJ; Nagengast FM; Drenth JP
Nucl Med Biol; 2006 Feb; 33(2):245-8. PubMed ID: 16546679
[TBL] [Abstract][Full Text] [Related]
34. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
35. Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue.
Baba S; Tatsumi M; Ishimori T; Lilien DL; Engles JM; Wahl RL
J Nucl Med; 2007 Jun; 48(6):981-6. PubMed ID: 17504863
[TBL] [Abstract][Full Text] [Related]
36. Tetraphenylphosphonium as a novel molecular probe for imaging tumors.
Min JJ; Biswal S; Deroose C; Gambhir SS
J Nucl Med; 2004 Apr; 45(4):636-43. PubMed ID: 15073261
[TBL] [Abstract][Full Text] [Related]
37. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
Koort JK; Mäkinen TJ; Knuuti J; Jalava J; Aro HT
J Nucl Med; 2004 Aug; 45(8):1406-11. PubMed ID: 15299068
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 4'-[methyl-11C]thiothymidine in a rodent tumor and inflammation model.
Toyohara J; Elsinga PH; Ishiwata K; Sijbesma JW; Dierckx RA; van Waarde A
J Nucl Med; 2012 Mar; 53(3):488-94. PubMed ID: 22315439
[TBL] [Abstract][Full Text] [Related]
39. Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism.
Babich JW; Tompkins RG; Graham W; Barrow SA; Fischman AJ
J Nucl Med; 1997 Aug; 38(8):1316-22. PubMed ID: 9255175
[TBL] [Abstract][Full Text] [Related]
40. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.
Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T
J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
